Anti-XYLT2 antibodies are used in the immunodetection of the protein xylosyltransferase 2. In humans, the canonical protein has a reported length of 865 amino acid residues and a mass of 96.8 kDa. Its subcellular localization is in the Golgi and is secreted. Up to 2 different isoforms have been reported for this protein. It is widely expressed across many tissue types. A member of the Glycosyltransferase 14 protein family, XYLT2 is known to catalyze the first step in the biosynthesis of chondroitin sulfate, heparan sulfate and dermatan sulfate proteoglycans, such as DCN. Post-translational modifications have been described, including glycosylation. Synonyms for this target antigen include peptide O-xylosyltransferase 1, protein xylosyltransferase 2, xylosyltransferase II, and UDP-D-xylose:proteoglycan core protein beta-D-xylosyltransferase. XYLT2 gene orthologs have been reported in the mouse, rat, bovine, frog, chimpanzee and chicken species. Some XYLT2 antibodies may have been used in research and have associated citations. Western Blot is a widely used application for these antibodies. In addition, ELISA is also a common application.